Biotransformation of xenobiotics in individual rabbit hepatocytes. Application of microspectrofluorometry. 1986

T E Massey, and T R Devereux, and J R Fouts

We have investigated several methods for determining rates of xenobiotic biotransformation in individual rabbit hepatocytes by microspectrofluorometry. Experiments designed to measure monooxygenase activity by following fluorescent product formation (i.e. 7-ethoxycoumarin deethylase or oxidation of the fluorescein derivatives ethoxyfluorescein ethyl ester and 5- and 6-ethoxycarbonyl ethoxyfluorescein ethyl ester) demonstrated that the fluorescent products were released from cells to the surrounding media. Thus, metabolically active cells probably had underestimated activities, and inactive cells could accumulate fluorescent product and appear metabolically active. We also utilized benzo(a)pyrene (BP) as a substrate in our system. By selecting appropriate wavelengths (370 nm excitation, 407 nm emission), it was possible to selectively monitor BP disappearance in single cells. In hepatocytes from rabbits, disappearance of fluorescence was observed after a 10-min incubation at 37 degrees C with 1-40 microM BP followed by a wash to remove extracellular substrate. The decrease in fluorescence followed apparent first-order kinetics. Measurement of extracellular fluorescence indicated that the substrate did not leave the hepatocytes. Furthermore, in both control and beta-naphthoflavone-treated rabbits, the observed fluorescence changes in the cells were inhibited by the presence of equimolar concentrations of ellipticine or alpha-naphthoflavone, inhibitors of BP metabolism. Storage of hepatocytes from untreated animals on ice for 3.5 hr did not affect rate constant values in cells with a normal appearance, whereas those lacking refringent edges or having numerous cytoplasmic blebs demonstrated greatly reduced (up to 88% loss) activities compared with normal, freshly isolated cells. Potential applications of this system (e.g. to other cell types) are discussed.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D004611 Ellipticines Pyrido-CARBAZOLES originally discovered in the bark of OCHROSIA ELLIPTICA. They inhibit DNA and RNA synthesis and have immunosuppressive properties.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001564 Benzo(a)pyrene A potent mutagen and carcinogen. It is a public health concern because of its possible effects on industrial workers, as an environmental pollutant, an as a component of tobacco smoke. 3,4-Benzopyrene,3,4-Benzpyrene,3,4 Benzopyrene,3,4 Benzpyrene
D001571 Benzoflavones Organic compounds containing a BENZENE ring attached to a flavone group. Some of these are potent arylhydrocarbon hydroxylase inhibitors. They may also inhibit the binding of NUCLEIC ACIDS to BENZOPYRENES and related compounds. The designation includes all isomers; the 7,8-isomer is most frequently encountered. Benzoflavone Compounds,Compounds, Benzoflavone
D001579 Benzopyrene Hydroxylase A drug-metabolizing, cytochrome P-448 (P-450) enzyme which catalyzes the hydroxylation of benzopyrene to 3-hydroxybenzopyrene in the presence of reduced flavoprotein and molecular oxygen. Also acts on certain anthracene derivatives. An aspect of EC 1.14.14.1. Benzopyrene-3-Monooxygenase,Benzo(a)pyrene Hydroxylase,Benzo(a)pyrene Monooxygenase,Benzopyrene 3 Monooxygenase,Hydroxylase, Benzopyrene
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

T E Massey, and T R Devereux, and J R Fouts
January 1994, Physiological research,
T E Massey, and T R Devereux, and J R Fouts
January 1980, Pharmacology & therapeutics,
T E Massey, and T R Devereux, and J R Fouts
December 1979, Environmental health perspectives,
T E Massey, and T R Devereux, and J R Fouts
January 2014, Nucleic acids research,
T E Massey, and T R Devereux, and J R Fouts
August 2020, Phytochemistry,
T E Massey, and T R Devereux, and J R Fouts
April 2001, Fundamental & clinical pharmacology,
T E Massey, and T R Devereux, and J R Fouts
November 2005, Drug metabolism and disposition: the biological fate of chemicals,
T E Massey, and T R Devereux, and J R Fouts
January 2021, Current drug metabolism,
T E Massey, and T R Devereux, and J R Fouts
June 1988, Xenobiotica; the fate of foreign compounds in biological systems,
T E Massey, and T R Devereux, and J R Fouts
December 2000, Current drug metabolism,
Copied contents to your clipboard!